Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,411 | 40,580 | 48,534 | 53,407 | 45,728 |
| Marketable Securities | 122,273 | 114,375 | 88,609 | 54,972 | 31,371 |
| Receivables | 49,945 | 51,763 | 45,925 | 39,907 | 41,547 |
| Inventories | 11,652 | 11,506 | 13,303 | 10,423 | 4,659 |
| TOTAL | $234,027 | $240,166 | $214,927 | $175,393 | $146,563 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 54 | 57 | 76 |
| Intangibles | 24,160 | 24,748 | 25,336 | 25,924 | 26,512 |
| Other Non-Current Assets | 246,421 | 248,680 | 2,217 | 5,362 | 2,821 |
| TOTAL | $270,581 | $273,428 | $27,607 | $31,343 | $29,409 |
| Total Assets | $504,608 | $513,594 | $242,534 | $206,736 | $175,972 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,486 | 7,191 | 3,846 | 7,290 | 3,954 |
| Accrued Expenses | 11,751 | 17,438 | 14,881 | 12,018 | 10,672 |
| Other current liabilities | 33,080 | 32,716 | 35,020 | 34,502 | 27,935 |
| TOTAL | $89,492 | $99,237 | $94,400 | $86,636 | $66,629 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,991 | 22,482 | 29,969 | 37,452 | 44,931 |
| Deferred Revenues | N/A | N/A | 1,355 | 1,355 | 1,355 |
| Other Non-Current Liabilities | 228 | 395 | 556 | 714 | 45,845 |
| TOTAL | $15,219 | $22,877 | $30,525 | $38,166 | $90,776 |
| Total Liabilities | $104,711 | $122,114 | $124,925 | $124,802 | $157,405 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 18,502 | 18,473 | 18,151 | 17,937 | 17,872 |
| Common Shares | 18 | 18 | 18 | 18 | 18 |
| Retained earnings | -1,014,387 | -1,023,041 | -1,291,106 | -1,319,006 | -1,378,619 |
| Other shareholders' equity | -128 | 181 | 96 | 6 | -2 |
| TOTAL | $399,897 | $391,480 | $117,609 | $81,934 | $18,567 |
| Total Liabilities And Equity | $504,608 | $513,594 | $242,534 | $206,736 | $175,972 |